冠状动脉疾病的新风险因素可以通过基于ApoA1 mAb的测试检测到
Hui Ding1, Yin Wang2, Yan Zhang3
1Department of Laboratory Medicine, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200336, China.
Clinica chimica acta; international journal of clinical chemistry
|December 10, 2023
概括
一种新的阿波利波蛋白A1 (ApoA1) 单克隆抗体 (mAb) 试验确定了与冠状动脉疾病 (CAD) 相关的高密度脂蛋白 (HDL) 子类. 这种分析有助于改善CAD风险评估.
科学领域:
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
- 心血管医学 心血管医学
背景情况:
- 冠状动脉疾病 (CAD) 是一个重大的全球健康挑战.
- 生物标志物用于早期和准确的CAD检测对于有效的管理至关重要.
- 阿波脂蛋白A1 (ApoA1) 是高密度脂蛋白 (HDL) 胆固醇的一个关键组成部分.
研究的目的:
- 为了识别与冠状动脉疾病 (CAD) 相关的阿波利波蛋白A1 (ApoA1) 单克隆抗体 (mAb).
- 为了评估使用这种ApoA1 mAb用于CAD的试验的诊断效用.
- 探索ApoA1子类与CAD风险之间的关系.
主要方法:
- 招募了180名CAD患者和199名健康对照.
- 用斯皮尔曼的等级相关性和逻辑回归来进行关联分析.
- 利用接收器操作特征 (ROC) 曲线分析来评估诊断准确性.
主要成果:
- ApoA1 mAb测量显示出与CAD的显著正相关性 (r=0.243,P<0.01).
- 在正常的HDL-C.的患者中,ApoA1 mAb测定表明ROC曲线下的面积为0.704.
- 来自mAb试验的ApoA1值对CAD风险评估产生了积极影响.
结论:
- 基于ApoA1 mAb的测试可以确定与CAD积极相关的HDL子类.
- 这种分析为增强和重新评估CAD风险分层提供了潜力.
- 这些发现表明了改善心血管风险评估的新方法.
更多相关视频
相关概念视频
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...